Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-05-20 Sale |
2021-05-24 06:24 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
18,746 | $35.5 | $665,439 | 1,011,137 (Direct) |
View |
2021-05-19 Sale |
2021-05-21 6:13 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
40,000 | $32.64 | $1,305,506 | 1,301,048 (Indirect) |
View |
2021-05-14 Sale |
2021-05-18 06:02 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
100 | $35 | $3,500 | 1,029,883 (Direct) |
View |
2021-05-12 Sale |
2021-05-14 06:04 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
11,876 | $35.44 | $420,892 | 1,029,983 (Direct) |
View |
2021-05-07 Sale |
2021-05-11 06:30 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
1,011 | $35.03 | $35,415 | 1,041,859 (Direct) |
View |
2021-05-05 Sale |
2021-05-07 07:22 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
7,138 | $35.14 | $250,803 | 1,042,870 (Direct) |
View |
2021-05-03 Sale |
2021-05-05 08:26 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
33,992 | $37 | $1,257,849 | 1,050,008 (Direct) |
View |
2021-05-03 Sale |
2021-05-04 8:31 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $37.84 | $548,656 | 765,700 (Indirect) |
View |
2021-04-05 Sale |
2021-04-07 4:13 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
40,000 | $36.55 | $1,462,089 | 1,341,048 (Indirect) |
View |
2021-04-01 Sale |
2021-04-05 7:01 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $36.63 | $531,102 | 780,200 (Indirect) |
View |
2021-03-22 Sale |
2021-03-23 7:22 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
11,513 | $43.32 | $498,751 | 855,687 (Direct) |
View |
2021-03-11 Sale |
2021-03-15 4:36 pm |
Phathom Pharmaceuticals Inc. | PHAT | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
710,000 | $43.75 | $31,062,500 | 3,115,008 (Indirect) |
View |
2021-03-10 Sale |
2021-03-12 5:54 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
55,000 | $47.58 | $2,617,090 | 1,381,048 (Indirect) |
View |
2021-03-01 Sale |
2021-03-03 8:20 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $45.88 | $665,290 | 795,533 (Indirect Direct) |
View |
2021-02-19 Sale |
2021-02-23 6:14 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
70,000 | $46.49 | $3,254,612 | 1,436,048 (Indirect) |
View |
2021-02-01 Sale |
2021-02-03 4:05 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $39.89 | $578,441 | 809,200 (Indirect) |
View |
2021-01-11 Sale |
2021-01-13 5:07 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
40,000 | $35.7 | $1,428,038 | 1,532,945 (Indirect) |
View |
2020-01-04 Sale |
2021-01-05 7:17 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $33.61 | $487,275 | 823,700 (Indirect) |
View |
2020-12-16 Sale |
2020-12-18 8:01 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
79,658 | $43.42 | $3,458,896 | 1,572,945 (Indirect) |
View |
2020-12-01 Sale |
2020-12-03 6:01 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $44.74 | $648,688 | 838,200 (Indirect) |
View |
2020-11-09 Sale |
2020-11-12 4:13 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
30,342 | $41.3 | $1,253,198 | 1,652,603 (Indirect) |
View |
2020-11-02 Sale |
2020-11-03 6:40 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
14,500 | $36.83 | $534,026 | 852,700 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-05-21 Option Award |
2021-05-24 5:29 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Yamada Tadataka Director |
12,500 | $0 | 12,500 (Direct) |
View |
2021-03-22 Exercise |
2021-03-23 7:22 pm |
N/A 2029-08-28 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
11,513 | $0 | 855,687 (Direct) |
View |
2021-03-22 Exercise |
2021-03-23 7:22 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
11,513 | $6.95 | 855,687 (Direct) |
View |
2020-12-01 Ownership |
2021-02-12 4:46 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
27,000 | $0 | 1,505,945 (Indirect) |
View |
2021-01-28 Option Award |
2021-01-29 4:32 pm |
N/A 2031-01-27 |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 4:28 pm |
N/A 2031-01-27 |
Phathom Pharmaceuticals Inc. | PHAT | Branning Todd P. Chief Financial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 4:27 pm |
N/A 2031-01-27 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
225,000 | $0 | 225,000 (Direct) |
View |
2020-06-25 Gift |
2020-11-03 6:40 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
867,200 | $0 | 852,700 (Direct) |
View |
2020-07-13 Option Award |
2020-07-13 4:50 pm |
N/A 2030-07-12 |
Phathom Pharmaceuticals Inc. | PHAT | Branning Todd P. Chief Financial Officer |
85,000 | $0 | 85,000 (Direct) |
View |
2020-07-01 Option Award |
2020-07-02 4:48 pm |
N/A 2030-06-30 |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
70,000 | $0 | 70,000 (Direct) |
View |
2020-07-01 Option Award |
2020-07-02 4:44 pm |
N/A 2030-06-30 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
175,000 | $0 | 175,000 (Direct) |
View |
2020-06-12 Other |
2020-06-16 5:42 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner |
1,456,854 | $0 | 7,315,715 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:06 pm |
N/A 2030-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Yamada Tadataka Director |
10,000 | $0 | 10,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:05 pm |
N/A 2030-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:03 pm |
N/A 2030-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | FIELDS HEIDI Director |
10,000 | $0 | 10,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:01 pm |
N/A 2030-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | COLA MICHAEL F Director |
10,000 | $0 | 10,000 (Direct) |
View |